Cite
HARVARD Citation
Papachristofilou, A. et al. (2019). Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer. Journal for immunotherapy of cancer. 7 (1), p. . [Online].